CHRM1 and viral infectious disease: The key findings of the current study reveal that mRNA vaccines encoding the fusion forms of A35R and M1R (VGPox 1 and VGPox 2) can efficiently stimulate high levels of both A35R and M1R antibodies and effectively neutralize live-virus infections in cell cultures.